These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23214092)

  • 1. [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: II. Pathophysiology; 3. Autoantibodies in rheumatoid arthritis].
    Murakami K; Fujii T; Mimori T
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2844-50. PubMed ID: 23214092
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: bayes clears the haze.
    Finckh A; Liang MH
    Ann Intern Med; 2007 Jun; 146(11):816-7. PubMed ID: 17548414
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
    Lee AN; Beck CE; Hall M
    Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological significance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Roubenoff R; Beckman E; Weinblatt M; Shadick N; Gregersen PK
    Ann Intern Med; 2008 Mar; 148(5):403; author reply 403-4. PubMed ID: 18316760
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological significance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Arkfeld DG
    Ann Intern Med; 2008 Mar; 148(5):403; author reply 403-4. PubMed ID: 18316759
    [No Abstract]   [Full Text] [Related]  

  • 6. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 7. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
    Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
    [No Abstract]   [Full Text] [Related]  

  • 8. Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor?
    Symmons DP
    Rheumatology (Oxford); 2007 May; 46(5):725-6. PubMed ID: 17215261
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progress on diagnostic tests for rheumatoid arthritis].
    Yamamoto K
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2380-6. PubMed ID: 19149032
    [No Abstract]   [Full Text] [Related]  

  • 10. A combined diagnostic approach to rheumatoid arthritis using anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Oommen S; Appalaraju B; Sivadarshini S;
    Indian J Med Microbiol; 2011; 29(2):195-6. PubMed ID: 21654124
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis.
    Mierau R; Genth E
    Clin Chem Lab Med; 2006; 44(2):138-43. PubMed ID: 16475897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination of rheumatoid factor and other serum markers in rheumatoid arthritis].
    Hiura K; Iwaki-Egawa S; Matsuno H; Watanabe Y
    Yakugaku Zasshi; 2005 Nov; 125(11):881-7. PubMed ID: 16272809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological and serological tests for diagnosis of rheumatoid arthritis--introduction].
    Tanaka M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():310-2. PubMed ID: 15799368
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies in normals--the value of predicting rheumatoid arthritis.
    Dörner T; Hansen A
    Arthritis Res Ther; 2004; 6(6):282-4. PubMed ID: 15535841
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-34: a potential diagnostic and therapeutic target for rheumatoid arthritis.
    He W; Xu XD; Dong YM; Wu H
    J Rheumatol; 2015 Mar; 42(3):553. PubMed ID: 25729045
    [No Abstract]   [Full Text] [Related]  

  • 17. Dimethylated L-arginine analogues versus autoantibodies in early rheumatoid arthritis.
    Korkosz M; Sulicka J; Surdacki A
    Scand J Rheumatol; 2012 Feb; 41(1):82-3. PubMed ID: 22283801
    [No Abstract]   [Full Text] [Related]  

  • 18. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.
    Nishimura K; Sugiyama D; Kogata Y; Tsuji G; Nakazawa T; Kawano S; Saigo K; Morinobu A; Koshiba M; Kuntz KM; Kamae I; Kumagai S
    Ann Intern Med; 2007 Jun; 146(11):797-808. PubMed ID: 17548411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic significance of combined detection of rheumatoid factor and anticyclic citrullinated peptide antibodies in rheumatoid arthritis].
    Mu R; Sun XY; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):498-500. PubMed ID: 16224521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.